BASF Aktiengesellschaft’s Fine Chemicals division is expanding its production site for pharmaceutical active ingredients in Minden, Germany, and is investing an eight-digit sum in the construction of a new multi-product plant. The plant, which is expected to start operations in late 2004, will manufacture pharmaceutical active ingredients and intermediates. Flexible equipment will allow rapid product changeovers and the use of new technologies. The Minden site is particularly suitable for the planned capital expenditure in view of its expertise and many years of experience in manufacturing and handling pharmaceutical active ingredients such as pseudoephedrine and caffeine. All the major European and US regulatory authorities have repeatedly inspected and approved Minden as a production site for pharmaceutical ingredients.
Looking for more projects or tenders?
Subscribe to our Project Preview Newsletter
